VTL Stock Overview
VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
VGI Health Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.03 |
| 52 Week Low | AU$0.02 |
| Beta | 0.56 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| VTL | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | -0.2% |
| 1Y | n/a | -4.2% | 8.9% |
Return vs Industry: Insufficient data to determine how VTL performed against the Australian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how VTL performed against the Australian Market.
Price Volatility
| VTL volatility | |
|---|---|
| VTL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.2% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in AU Market | 16.4% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: VTL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VTL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Glenn Tong | vgiht.com |
VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies. It offers drugs and wellbeing supplements. The company also develops nE1-Heart for treatment of hyperlipidaemia; and nE1-Elite that reduce delayed onset muscle soreness, enhance muscle recovery, and provide exercise endurance and maintenance of muscle power.
VGI Health Technology Limited Fundamentals Summary
| VTL fundamental statistics | |
|---|---|
| Market cap | AU$2.76m |
| Earnings (TTM) | -AU$1.52m |
| Revenue (TTM) | AU$24.60k |
112.4x
P/S Ratio-1.8x
P/E RatioIs VTL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTL income statement (TTM) | |
|---|---|
| Revenue | AU$24.60k |
| Cost of Revenue | AU$20.74k |
| Gross Profit | AU$3.86k |
| Other Expenses | AU$1.53m |
| Earnings | -AU$1.52m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 15.69% |
| Net Profit Margin | -6,186.86% |
| Debt/Equity Ratio | -393.5% |
How did VTL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/09/25 15:18 |
| End of Day Share Price | 2023/06/29 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
VGI Health Technology Limited is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marc Kennis | APP Securities Pty Ltd. |
| Jaywant Srivatsa | Chardan Capital Markets, LLC |
| Darren Paul Aftahi | Northland Capital Markets |